ProQR Therapeutics N.V. (PRQR)

ProQR Therapeutics Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	119.77	149.41	118.93	94.78	187.52	75.84
Cash & Short-Term Investments	119.77	149.41	118.93	94.78	187.52	75.84
Cash Growth	24.56%	25.63%	25.48%	-49.46%	147.27%	-32.26%
Accounts Receivable	-	-	-	56.25	-	-
Other Receivables	2.43	2.03	1.27	0.98	0.82	0.8
Receivables	2.43	2.03	1.27	57.24	0.82	0.8
Prepaid Expenses	2.09	2.41	0.79	2.45	3.14	3.38
Total Current Assets	124.28	153.85	120.99	154.46	191.48	80.02
Property, Plant & Equipment	13.26	14.11	16.9	16.24	17.47	18.6
Long-Term Investments	-	-	-	0.62	0.63	0.11
Total Assets	137.54	167.96	137.88	171.32	209.58	98.73
Accounts Payable	1.28	0.02	1.54	0.39	0.19	0.22
Accrued Expenses	0.28	1.48	1.66	1.12	1.23	6.15
Current Portion of Long-Term Debt	4.73	4.58	-	2.5	4.77	1.14
Current Portion of Leases	1.65	1.57	1.61	1.39	1.53	1.26
Current Unearned Revenue	17.45	21.94	20.57	5.64	5.12	0.7
Other Current Liabilities	7.69	9.32	8.82	9.95	14.76	0.84
Total Current Liabilities	33.09	38.9	34.2	20.99	27.6	10.3
Long-Term Debt	-	-	4.29	4.27	39.32	16.19
Long-Term Leases	10.48	11.07	13.83	13.81	14.75	15.69
Long-Term Unearned Revenue	26.99	29.43	44.17	65.57	14.69	-
Total Liabilities	70.55	79.4	96.49	104.64	96.35	42.18
Common Stock	4.31	4.31	3.37	3.37	3	2.17
Additional Paid-In Capital	483.88	483.81	412.89	412.54	398.31	288.76
Retained Earnings	-447.77	-427.16	-400.85	-379.11	-317.77	-257.75
Comprehensive Income & Other	26.57	27.6	25.98	30.26	30.3	23.92
Total Common Equity	66.98	88.56	41.39	67.07	113.83	57.09
Minority Interest	-	-	-	-0.38	-0.6	-0.55
Shareholders' Equity	66.98	88.56	41.39	66.68	113.23	56.55
Total Liabilities & Equity	137.54	167.96	137.88	171.32	209.58	98.73
Total Debt	16.86	17.22	19.73	21.97	60.37	34.28
Net Cash (Debt)	102.9	132.19	99.19	72.8	127.15	41.56
Net Cash Growth	33.70%	33.27%	36.24%	-42.74%	205.94%	-57.76%
Net Cash Per Share	1.05	1.54	1.22	1.02	1.98	0.83
Filing Date Shares Outstanding	105.34	105.21	81.35	80.82	71.29	50.2
Total Common Shares Outstanding	105.34	105.21	81.35	80.82	71.29	50.2
Working Capital	91.19	114.94	86.78	133.47	163.89	69.72
Book Value Per Share	0.64	0.84	0.51	0.83	1.60	1.14
Tangible Book Value	66.98	88.56	41.39	67.07	113.83	57.09
Tangible Book Value Per Share	0.64	0.84	0.51	0.83	1.60	1.14
Buildings	-	23.79	24.78	22.86	22.23	21.64
Machinery	-	6.82	5.91	4.91	4.25	3.63

Updated Aug 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q